ENTX

Entera Bio Ltd.

Price

$2.93

return (12m)

62.78%

p/e

-8.68

p/bv

20.34

DIVIDEND YIELD

0.00%

ENTX price

Entera Bio

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ENTX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-10.94%

3 months

140.16%

1 year

62.78%

2 years

44.33%

5 years

-36.85%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals ENTX

Valuation

P/E

-8.68

Sector -3.50

Industry -3.50

P/BV

20.34

Sector 2.02

Industry 2.02

P/Revenue (PSR)

Sector 2.01

Industry 2.01

EV/EBITDA

-30.04

Sector -214.99

Industry -214.99

EV/EBIT

-29.98

Sector -47.59

Industry -47.59

P/EBITDA

-10.29

Sector -21.41

Industry -21.41

P/EBIT

-10.27

Sector -28.65

Industry -28.65

P/Total Assets

7.59

Sector 1.19

Industry 1.19

P/Net Current Assets

22.12

Sector -11.97

Industry -11.97

P/Working Capital

8.80

Sector -167.95

Industry -167.95

EPS

-0.34

Sector -1.81

Industry -1.81

BVPS

0.14

Sector 2.06

Industry 2.06

Efficiency

Gross Margin

0.00%

Sector 41.30%

Industry 41.30%

EBITDA Margin

Sector -17,117.21%

Industry -17,117.21%

EBIT Margin

Sector -4,185,659.35%

Industry -4,185,659.35%

Operating Margin

0.00%

Sector -35.21%

Industry -35.21%

Net Profit Margins

0.00%

Sector -35.91%

Industry -35.91%

Asset Turnover

0.00

Sector 0.02

Industry 0.02

Profitability

ROE

-234.42%

Sector -56.04%

Industry -56.04%

ROA

-87.44%

Sector -60.31%

Industry -60.31%

ROIC

-245.80%

Sector -2,335.95%

Industry -2,335.95%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

8.98

Sector 2.89

Industry 2.89

Net Debt / EBITDA

2.42

Sector -14,066,680.10

Industry -14,066,680.10

Net Debt / EBIT

2.42

Sector -8.06

Industry -8.06

Net Debt / Equity

-1.52

Sector -33,024.69

Industry -33,024.69

Gross Debt / Equity

0.04

Sector -0.85

Industry -0.85

Equity/Assets

0.37

Sector 0.46

Industry 0.46

Liabilities/Assets

0.63

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

-6.76%

Sector -

Industry -

Fundamentals ENTX

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ENTX Entera Bio Ltd.	$2.93	65.54%	0.00%	-8.68	20.34	-234.42%	0.00%
JNJ Johnson & Johnson	$269.33	55.44%	1.96%	30.82	7.63	24.76%	21.48%
PFE Pfizer Inc.	$27.49	22.33%	6.26%	35.85	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$263.93	23.34%	2.59%	73.99	-78.76	-106.44%	9.81%
NVO Novo Nordisk A/S	$43.19	-26.70%	4.29%	10.56	5.61	53.11%	35.32%
MRK Merck & Co. Inc.	$146.11	87.14%	2.31%	113.21	8.55	7.55%	4.76%
AZN AstraZeneca PLC	$166.35	9.78%	1.94%	19.88	5.12	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$62.71	43.77%	4.04%	13.67	5.68	41.55%	18.85%
ZTS Zoetis Inc.	$72.66	-49.60%	2.88%	11.47	9.64	84.02%	27.77%
AMGN Amgen Inc.	$383.04	43.28%	2.60%	23.66	17.70	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$784.44	31.54%	0.47%	18.63	2.54	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$111.35	46.87%	0.00%	31.57	90.97	288.13%	24.86%
MCK McKesson Corporation	$874.67	27.00%	0.38%	19.57	-26.84	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$506.08	30.72%	0.00%	29.15	6.34	21.76%	35.00%
CAH Cardinal Health Inc.	$224.45	52.89%	0.91%	30.53	-19.32	-63.29%	0.68%
ARGX argenx SE	$994.44	35.42%	0.00%	2.24	2.63	117.11%	44.68%
HRMY Harmony Biosciences Holdings Inc.	$42.23	31.71%	0.00%	13.50	2.45	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ENTX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Entera Bio

Entera Bio Ltd.

Average Investor10 user rating

4.0 (0 people)

United States

17 years

Founded: 2009

2018

Time since IPO - 8 years

24

Employees

Entera Bio Ltd. (United States) is listed on the Nasdaq and has a market capitalization of $147.82 million, with shareholders equity totaling $7.27 million.

The company employs approximately 24 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Entera Bio Ltd. reported $- in revenue, generating net income of $-17.03 million.

Key financial metrics include a P/E ratio of -8.68, a price-to-book (P/B) ratio of 20.34, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ENTX.

Market cap

$147.82 million

Net worth

$7.27 million

$7,266,000.00

Assets

$19.48 million

$19,480,000.00

Total Shares Outstanding

50.45 million

50,451,000

Average Daily Trading Volume

$2.18 million

$2,184,648.14

Sector

Health Care

Industry

Biotechnology

ENTX

ENTX revenue and profits

Financial Results ENTX

DRAG THE FRAME TO SEE MORE DATA

ENTX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$874.67 25,76% (12M)

P/E

19.57

0.38%

ROE

-137.16%

P/BV

-26.84

CAH - Cardinal Health

$224.45 51,61% (12M)

P/E

30.53

0.91%

ROE

-63.29%

P/BV

-19.32

JNJ - Johnson & Johnson

$269.33 56,33% (12M)

P/E

30.82

1.96%

ROE

24.76%

P/BV

7.63

ABBV - AbbVie

$263.93 22,42% (12M)

P/E

73.99

2.59%

ROE

-106.44%

P/BV

-78.76

MRK - Merck & Co.

$146.11 85,19% (12M)

P/E

113.21

2.31%

ROE

7.55%

P/BV

8.55

AZN - AstraZeneca

$166.35 9,17% (12M)

P/E

19.88

1.94%

ROE

25.77%

P/BV

5.12

PFE - Pfizer

$27.49 22,43% (12M)

P/E

35.85

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$874.67 25,76% (12 M)

P/L

19.57

0.38%

ROE

-137.16%

P/VP

-26.84

CAH - Cardinal Health

$224.45 51,61% (12 M)

P/L

30.53

0.91%

ROE

-63.29%

P/VP

-19.32

JNJ - Johnson & Johnson

$269.33 56,33% (12 M)

P/L

30.82

1.96%

ROE

24.76%

P/VP

7.63

ABBV - AbbVie

$263.93 22,42% (12 M)

P/L

73.99

2.59%

ROE

-106.44%

P/VP

-78.76

MRK - Merck & Co.

$146.11 85,19% (12 M)

P/L

113.21

2.31%

ROE

7.55%

P/VP

8.55

AZN - AstraZeneca

$166.35 9,17% (12 M)

P/L

19.88

1.94%

ROE

25.77%

P/VP

5.12

PFE - Pfizer

$27.49 22,43% (12 M)

P/L

35.85

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Entera Bio (ENTX) today?

A cotação de Entera Bio (ENTX) hoje está em US$ 2.93, com uma variação de 62.78% em relação ao último ano. A cotação de Entera Bio (ENTX) iniciou o ano negociando na casa dos US$ 1.94 e hoje está em US$ 2.93. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Entera Bio (ENTX) e dados de ações do Ibovespa e mercados internacionais.

Quando Entera Bio (ENTX) paga dividendos?

Entera Bio (ENTX) não distribuiu dividendos no último ano.

Is Entera Bio (ENTX) a good investment?

Atualmente, Entera Bio (ENTX) está cotada a US$ 2.93, com um P/L de -8.68, representando um desvio de -590% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 62.78 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 62.78%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Entera Bio (ENTX) stock?

Investir em ações de Entera Bio (ENTX) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Entera Bio (ENTX) yield today?

A rentabilidade de Entera Bio (ENTX) foi de -10.94% no último mês, 62.78% no último ano e -36.85% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Entera Bio (ENTX) hoje, o investimento total seria de US$ 293.00, com base na cotação atual de US$ 2.93.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 476.95
Em 5 anos: US$ 185.03
Em 10 anos: US$ 293.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ENTX

Entera Bio Ltd.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ENTX

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING ENTX WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Entera Bio

Entera Bio Ltd.

United States

17 years

2018

24

PROFIT X PRICE ENTX

Financial Results ENTX

ENTX cash flow

Asset, Revenue and Profit Growth - ENTX

ENTX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions